NCT06478134View on ClinicalTrials.gov

Efficacy and Safety of a Multiple-Action Tear Substitute (TriMix) in Dry Eye Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

January 10, 2024

Study Completion Date

May 1, 2024

Conditions
Dry Eye
Interventions
DRUG

Trimix tear substitutes

Patients were instructed to instill 1 drop of TriMix tear substitute into each eye 3 times per day for 6 months.

DRUG

Hyaluronic acid tear substitute

Patients were instructed to instill 1 drop of 0.15% HA tear substitute into each eye 3 times per day for 6 months.

Trial Locations (1)

30009

Novovision ophthalmologic clinic, Murcia

All Listed Sponsors
lead

University of Seville

OTHER